Chemical accumulation from UGT1A1 dysfunction promotes DNA damage and tumor risk, while genetic variations in UGT1A1 can affect GC risk via modifying the enzyme’s chemical elimination (Pereira et al., 2022). The gene discussed is UGT1A1; the disease is neoplasm.